Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Dec;57(1):2533425.
doi: 10.1080/07853890.2025.2533425. Epub 2025 Jul 23.

Association between cardiac dysfunction and late gadolinium enhancement confined to the LV intramural region in patients with hypertrophic cardiomyopathy

Affiliations

Association between cardiac dysfunction and late gadolinium enhancement confined to the LV intramural region in patients with hypertrophic cardiomyopathy

Zhi Yang et al. Ann Med. 2025 Dec.

Abstract

Aim/introduction: There are two major distributions of late gadolinium enhancement (LGE) in the context of hypertrophic cardiomyopathy (HCM): intramural LGE and LGE at right ventricular insertion points (RVIPs). However, the clinical significance of intramural LGE has not been well established.

Materials and methods: A total of 117 consecutive patients with HCM (61 male; median age, 58.8 years) confirmed by cardiovascular magnetic resonance (CMR) were enrolled, and classified into three groups: (1) no LGE (n = 48), (2) intramural LGE (n = 49), and (3) RVIP LGE (n = 20).

Results: Intramural LGE was detected in 41% of patients with HCM. HCM patients with intramural LGE had greater left ventricular (LV) wall thickness (LVWT) and greater LV mass than those without LGE (all p < 0.05). Furthermore, HCM patients with intramural LGE had a more depressed LV ejection fraction (LVEF) and more impaired global radial strain (GRS), global circumferential strain (GCS), and global longitudinal strain (GLS) than did those with RVIP LGE and those without LGE (all p < 0.05). Multivariate logistic regression analysis revealed that young age and severely thickened LVWT were associated with intramural LGE in patients with HCM (all p < 0.05). Furthermore, negative correlations were observed between intramural LGE and GRS, GCS, and GLS (all p < 0.001).

Conclusions: Intramural LGE is associated with more severe HCM phenotypes, including a greater LVWT, LV mass and extent of LGE; a reduced LVEF; and impaired myocardial strain. These findings indicate that intramural LGE may be a noninvasive biomarker for risk stratification in patients with HCM.

Keywords: Cardiac magnetic resonance imaging; hypertrophic cardiomyopathy; late gadolinium enhancement; strain.

PubMed Disclaimer

Conflict of interest statement

No potential conflict of interest was reported by the author(s).

Figures

Figure 1.
Figure 1.
Late gadolinium enhancement (LGE) patterns for each group. Representative short-axis LGE images of HCM patients showing LGE located at right ventricle insertion points (RVIP LGE) only (B and D, white arrows) and patients with intramural LGE (C and D, yellow arrows). The figure in the bottom right corner shows a patient without LGE (A).
Figure 2.
Figure 2.
Differences in global radial strain (A, %), global circumferential strain (B, %) and global longitudinal strain (C, %) in HCM patients without late gadolinium enhancement (LGE), those with intramural LGE and those with LGE located in the right ventricle insertion points (RVIP LGE) only. **p < 0.01, ***p < 0.001, ****p < 0.0001.

Similar articles

References

    1. Marian AJ, Braunwald E.. Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res. 2017;121(7):749–770. doi: 10.1161/CIRCRESAHA.117.311059. - DOI - PMC - PubMed
    1. Weng Z, Yao J, Chan RH, et al. Prognostic value of LGE-CMR in HCM: a meta-analysis. JACC Cardiovasc Imaging. 2016;9(12):1392–1402. doi: 10.1016/j.jcmg.2016.02.031. - DOI - PubMed
    1. Kamp NJ, Chery G, Kosinski AS, et al. Risk stratification using late gadolinium enhancement on cardiac magnetic resonance imaging in patients with hypertrophic cardiomyopathy: a systematic review and meta-analysis. Prog Cardiovasc Dis. 2021;66:10–16. doi: 10.1016/j.pcad.2020.11.001. - DOI - PubMed
    1. Georgiopoulos G, Figliozzi S, Pateras K, et al. Comparison of demographic, clinical, biochemical, and imaging findings in hypertrophic cardiomyopathy prognosis: a network meta-analysis. JACC Heart Fail. 2023;11(1):30–41. doi: 10.1016/j.jchf.2022.08.022. - DOI - PubMed
    1. Cardim N, Galderisi M, Edvardsen T, et al. Role of multimodality cardiac imaging in the management of patients with hypertrophic cardiomyopathy: an expert consensus of the European Association of Cardiovascular Imaging Endorsed by the Saudi Heart Association. Eur Heart J Cardiovasc Imaging. 2015;16(3):280–280. doi: 10.1093/ehjci/jeu291. - DOI - PubMed

MeSH terms

LinkOut - more resources